These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9386228)

  • 41. A close look at fenfluramine and dexfenfluramine.
    Vivero LE; Anderson PO; Clark RF
    J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Xenical--a modern perspective drug for the treatment of obesity (review)].
    Mkrtumian AM; Biriukova EV
    Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging pharmacotherapy for obesity.
    Aronne LJ; Powell AG; Apovian CM
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):587-96. PubMed ID: 21834735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacotherapy of obesity].
    Svendsen OL
    Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmaceutical approaches to the treatment of obesity.
    Jandacek RJ; Woods SC
    Drug Discov Today; 2004 Oct; 9(20):874-80. PubMed ID: 15475320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical therapy for obesity--current status and future hopes.
    Bray GA
    Med Clin North Am; 2007 Nov; 91(6):1225-53, xi. PubMed ID: 17964918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AOD-9604 Metabolic.
    Wilding J
    Curr Opin Investig Drugs; 2004 Apr; 5(4):436-40. PubMed ID: 15134286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Taranabant, a novel cannabinoid type 1 receptor inverse agonist.
    Fremming BA; Boyd ST
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1116-29. PubMed ID: 18821475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exenatide. Amylin/Eli Lilly.
    Giannoukakis N
    Curr Opin Investig Drugs; 2003 Apr; 4(4):459-65. PubMed ID: 12808888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
    Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two new drugs approved for obesity.
    Johnson AM
    S D Med; 2012 Sep; 65(9):356-7. PubMed ID: 23066610
    [No Abstract]   [Full Text] [Related]  

  • 53. Another type of intervention: treating obesity with medication.
    Greenway F
    J Am Diet Assoc; 2005 Jun; 105(6):895-8. PubMed ID: 15942538
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of obesity: an update on anti-obesity medications.
    Halpern A; Mancini MC
    Obes Rev; 2003 Feb; 4(1):25-42. PubMed ID: 12608525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lower dosages of phentermine-fenfluramine given in the afternoon: five cases with significant weight loss.
    Katz DA; Maloney MJ; Sutkamp JC; McConville BJ
    Int J Eat Disord; 1999 May; 25(4):469-74. PubMed ID: 10202659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 57. Panel meeting prompts excitement for antiobesity drug.
    Mullard A
    Lancet; 2012 Mar; 379(9819):882. PubMed ID: 22413140
    [No Abstract]   [Full Text] [Related]  

  • 58. Unambiguous identification of obesity trials.
    Zarin DA; Tse T
    N Engl J Med; 2013 Feb; 368(6):580-1. PubMed ID: 23388022
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of obesity with fenfluramine (Ponderal) in general practice].
    Schiøttz-Christensen E
    Ugeskr Laeger; 1979 Sep; 141(39):2660-2. PubMed ID: 394442
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical trial of a new long-acting fenfluramine in the treatment of obesity].
    Pugnoli C; Bandini L; Caronna S; Ciarlini E; Magnati G; Strata A; Tirelli F
    G Clin Med; 1978 Nov; 59(11):486-510. PubMed ID: 369930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.